Production (Stage)
Organogenesis Holdings Inc.
ORGO
$3.03
$0.155.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -31.55% | 9.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -31.55% | 9.97% | |||
| Cost of Revenue | -23.60% | 15.88% | |||
| Gross Profit | -34.14% | 8.17% | |||
| SG&A Expenses | -1.82% | 2.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.21% | 6.89% | |||
| Operating Income | -297.47% | 63.71% | |||
| Income Before Tax | -351.47% | 76.08% | |||
| Income Tax Expenses | -368.99% | 139.64% | |||
| Earnings from Continuing Operations | -345.58% | -37.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -345.58% | -37.77% | |||
| EBIT | -297.47% | 63.71% | |||
| EBITDA | -208.35% | 37.78% | |||
| EPS Basic | -477.48% | -51.29% | |||
| Normalized Basic EPS | -292.51% | 79.64% | |||
| EPS Diluted | -526.43% | -55.44% | |||
| Normalized Diluted EPS | -296.08% | 78.31% | |||
| Average Basic Shares Outstanding | -2.61% | -2.18% | |||
| Average Diluted Shares Outstanding | -4.44% | -1.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||